- Targeted Testing of TB
Mazurek GH, Villarino ME. Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. Centers for Disease Control and Prevention. MMWR Recomm Rep. Jan 31 2003;52(RR-2):15-18.
Underwood BR, White VL, Baker T, Law M, Moore-Gillon JC. Contact tracing and population screening for tuberculosis--who should be assessed? J Public Health Med. Mar 2003;25(1):59-61.
Fietta A, Meloni F, Cascina A, et al. Comparison of a whole-blood interferon-gamma assay and tuberculin skin testing in patients with active tuberculosis and individuals at high or low risk of Mycobacterium tuberculosis infection. Am J Infect Control. Oct 2003;31(6):347-353
- Treatment of Latent TB Infection
Gershon AS, McGeer A, et al. Health care workers and the initiation of treatment for latent tuberculosis infection. Clin Infect Dis. 2004;39(5):667-72.
Horsburgh CR, Jr. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med. 2004;350(20):2060-7.
McNeill L, Allen M, Estrada C, Cook P. Pyrazinamide and rifampin vs isoniazid for the treatment of latent tuberculosis: improved completion rates but more hepatotoxicity. Chest. 2003;123(1):102-106.
White MC, Gournis E, Kawamura M, Menendez E, Tulsky JP. Effect of directly observed preventive therapy for latent tuberculosis infection in San Francisco. Int J Tuberc Lung Dis. Jan 2003;7(1):30-35.
